Effective May 13, 2024, Messrs. Berner and McKinney stepped down as executive officers of the Company, and the following individuals became the executive officers of the Company, with the respective position(s) set forth in the table below: Name Position Richard O’Dell Chief Executive Officer
Departed
Jeffrey Painter
Chief Executive Officer and President
Cardinal Ethanol LLC
Effective
2024-12-31
Filed
May 15, 2024, 7:59 PM ET
On May 15, 2024, Jeffrey Painter announced his plans to retire from his position as Chief Executive Officer and President of Cardinal Ethanol, LLC
The Board of Directors of Pulse Biosciences, Inc. (the “Company”) has appointed Burke T. Barrett as President and Chief Executive Officer of the Company and as a director, in each case effective as of May 12, 2024
On May 13, 2024, Starlette B. Johnson, Interim Chief Executive Officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”) and member of the Company’s Board of Directors (the “Board”), resigned from her position as Interim Chief Executive Officer effective immediately.
the board of directors (the “ Board ”) of the Company announced that it appointed Paul Gohr, age 42, as Chief Financial Officer of the Company, effective May 16, 2024
the Company announced that Stephanie Hogue, the Company’s current President, Chief Financial Officer, Secretary and Treasurer, resigned from her role as Chief Financial Officer of the Company, effective as of the Effective Date.
On May 14, 2024, the board of directors (the “Board”) of the Company appointed David Desharnais as Chief Executive Officer of the Company, effective May 16, 2024.
John D. Baker II, Chief Executive Officer and Chairman of the Board of Directors of FRP Holdings, Inc. (the “ Company ”) announced his retirement from his position as Chief Executive Officer, effective immediately.
the Board of Directors unanimously appointed Matthew C. McNulty as the Company’s Chief Financial Officer. His employment will be effective May 31, 2024.
the Board of Directors of the Company approved the appointment of Staci Woolsey as the Company’s Executive Vice President, Chief Financial Officer effective September 16, 2024.
Lisa Curtis notified Granite Construction Incorporated (the “Company”) that she will retire as the Company’s Executive Vice President, Chief Financial Officer on September 16, 2024.
Appointed
Brett Brbovic
Executive Vice President and Chief Financial Officer
Randall C. Schatzman, Ph.D. is stepping down as the Company’s Chief Executive Officer and has resigned as a member of the Board, both effective as of May 15, 2024.
Appointed
Matthew Batteh
Executive Vice President, Chief Financial Officer and Secretary
The Board of Directors ("Board") of Saia, Inc. (the "Company") has appointed Matthew Batteh, age 35, as the Executive Vice President and Chief Financial Officer and Secretary of the Company, effective May 13, 2024.
Mr. Batteh is replacing Douglas L. Col who previously announced his retirement.
Appointed
Michael Faerm
Chief Financial Officer
Viracta Therapeutics, Inc.
Effective
2024-05-13
Filed
May 14, 2024, 7:59 PM ET
On May 11, 2024, the Board of Directors ("Board") of Viracta Therapeutics, Inc. (the "Company") appointed Michael Faerm to serve as the Company’s Chief Financial Officer, effective May 13, 2024
Effective upon Mr. Rizvi’s departure, Jack Pacheco, the Company’s former CFO and current chief operating officer and president of Memory Solutions, will assume the role of interim CFO and serve as the Company’s principal financial and accounting officer on an interim basis until the Company appoints a permanent successor.
On May 8, 2024, Ken Rizvi notified SMART Global Holdings, Inc. (the “Company”) that after over three years as the Company’s senior vice president and chief financial officer (“CFO”), he intends to resign to pursue another opportunity.
On May 14, 2024, Synaptics Incorporated (the “Company”) announced that Ken Rizvi will join the Company as its Chief Financial Officer, effective on July 15, 2024 (the “Effective Date”).
On the Effective Date, in connection with Mr. Rizvi’s appointment, Michael Hurlston will cease to serve as the Company’s principal financial officer but will continue to serve as the Company’s President and Chief Executive Officer.
The Board of Directors of SEATech Ventures Corp. (the “Company”) received notification from Mr. Prabodh Kumar A/L Kantilal H Sheth that, effective on May 08, 2024, he resigns as Chief Financial Officer of the Company.
On May 7, 2024, Stephen E. Kuczynski, Chairman and Chief Executive Officer of Southern Nuclear Operating Company, Inc. (“Southern Nuclear”) and a named executive officer of The Southern Company, notified Southern Nuclear of his retirement, effective June 28, 2024.
Appointed
John R. Stewart
Executive Vice President and Chief Financial Officer
appoint him to serve as the Executive Vice President and Chief Financial Officer ("CFO") of both Horizon and its wholly-owned bank subsidiary, Horizon Bank (the "Bank"), to be effective as of May 20, 2024.
On May 9, 2024, the Board of Directors of the Company (the "Board") notified Scipio "Max" Carnecchia that his employment as the Company's Chief Executive Officer would terminate as of May 31, 2024.
Michael P. Zechmeister will be departing from his position as Chief Financial Officer of the Company after a successor is appointed or no later than May 31, 2024, at which time Mr. Zechmeister plans to retire.
Departed
Stephen L. Faulkner, Jr.
Chief Financial Officer and Chief Accounting Officer
As previously reported, on March 12, 2024, Stephen L. Faulkner, Jr. (Larry) informed Empire Petroleum Corporation (the "Company") that he was resigning as Chief Financial Officer and Chief Accounting Officer of the Company effective on March 28, 2024.
On May 10, 2024, the Board of Directors of the Company appointed Michael R. Morrisett, the Company’s President and Chief Executive Officer, to temporarily serve as the Company’s principal financial officer until the Company hires a replacement principal financial officer.
On May 13, 2024, the Board of Directors (the “Board”) of V2X, Inc. (the “Company”) announced the appointment of Mr. Jeremy Wensinger as President, Chief Executive Officer (“CEO”), and a Class III Director of the Board, effective June 17, 2024.
Departure of Charles Prow as President, Chief Executive Officer On May 9, 2024, Mr. Prow was separated as President and CEO of the Company, effective June 17, 2024.
Appointed
Sumit Kapur
Chief Financial Officer, Principal Financial and Accounting Officer and Treasurer
On May 8, 2024, the board of directors of Zapata Computing Holdings Inc. (the “Company”) appointed Sumit Kumar as the Company’s Chief Financial Officer, Principal Financial and Accounting Officer and Treasurer effective on May 20, 2024.
On May 8, 2024, Mimi Flanagan, the Chief Financial Officer and Treasurer of the Company, notified the Company that she will be resigning from her positions effective May 20, 2024.
On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.
Appointed
Scott A. Cox
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
FORMATION MINERALS, INC.
Effective
2024-05-09
Filed
May 13, 2024, 7:59 PM ET
appointed Scott A. Cox to serve as the sole director of the Board, to hold office until the next annual meeting of stockholders of the Company at which directors are being elected or as set forth in our Amended and Restated Bylaws (as defined below), and as the President, Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary of the Company
In addition, at the Second Merger Effective Time, Scott A. Cox, Chief Executive Officer, ceased serving in such positions.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.